Showing results (501-510 of 817) with videos related to
Sort By:
Pageof 82
Enfermedades Infecciosas Y Microbiologia Clinica|May 7, 2003
[Acinetobacter baumannii bacteremia: clinical and prognostic features]Jesús Rodríguez-Baño, Alvaro Pascual, Juan Gálvez, et al.Brain Stimulation|February 7, 2012
Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practicesAngel V Peterchev, Timothy A Wagner, Pedro C Miranda, et al.Restorative Neurology and Neuroscience|July 13, 2014
Language improvements after TMS plus modified CILT: Pilot, open-protocol study with two, chronic nonfluent aphasia casesPaula I Martin, Ethan Treglia, Margaret A Naeser, et al.Experimental Gerontology|February 20, 2026
Characterization of EEG power spectrum correlates of standing and walking in older adults: A scoping reviewMelike Kahya, Yiting Li, Junhong Zhou, et al.Journal of Alzheimer'S Disease : JAD|April 25, 2022
The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future DirectionsDavid J Libon, Rod Swenson, Melissa Lamar, et al.Restorative Neurology and Neuroscience|August 18, 2010
Research with rTMS in the treatment of aphasiaMargaret A Naeser, Paula I Martin, Ethan Treglia, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 13, 2007
Visual phosphene perception modulated by subthreshold crossmodal sensory stimulationCiro Ramos-Estebanez, Lotfi B Merabet, Katsuyuki Machii, et al.Enfermedades Infecciosas Y Microbiologia Clinica|June 23, 2004
[Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)]Felipe Fernández-Cuenca, Alvaro Pascual, Anna Ribera, et al.Brain Stimulation|March 25, 2021
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot studyAlberto Benussi, Valentina Cantoni, Maria Sofia Cotelli, et al.Enfermedades Infecciosas Y Microbiologia Clinica|October 4, 2003
[Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)]Elena Loza, Rafael Cantón, Alvaro Pascual, et al.Pageof 82